anybody wonder why raj was meeting RBC CAPITAL 3/5 -3/7 in both europe and asia ??
surprised no one has speculated on this........RBC WEBSITE DISCUSSES THEIR healthcare sector services offered (by rbc) and they specifically state they work with biopharmas in usa, canada, europe, and asia. they do it as w/r to financing, M&A........... whatever a small cap growing biopharma could want..........
would be unexpectedly pleasant to have a close @ H.O.D.
would be unexpectedly wonderful if sppi/rbc come back to usa w/ new institutional big big big monied longs in sppi corp. start that squeeze thats overdue. 27 million shares !!
Yes, String, I'm very curious. As for your and Ouch's analysis as to what is going on with SPPI and our current no volume and price staying in the same range, I agree with both of you. Only the patient shareholders will be rewarded. Thank goodness, I'm a very patient person (*~*)
OT - my other stock I'm heavily invested in is doing quite well today, String (*~^) Was happy I bought a bunch of shares in the low to mid 5's!!
I know there is conjecture that it may be because a suitor is wanting to buy Spectrum. I think a more likely scenario may be that Spectrum may be working a deal to buy Topo. Spectrum has bought WWR on Z and A, they have WWR on Folotyn, why not B. It makes Spectrum much more marketable for a future buyout by a major international pharma.